Your browser is no longer supported. Please, upgrade your browser.
Settings
KMDA Kamada Ltd. daily Stock Chart
KMDA [NASD]
Kamada Ltd.
Index- P/E6.88 EPS (ttm)0.86 Insider Own27.75% Shs Outstand40.30M Perf Week11.70%
Market Cap238.55M Forward P/E13.77 EPS next Y0.43 Insider Trans0.00% Shs Float29.66M Perf Month11.91%
Income- PEG1.15 EPS next Q0.15 Inst Own25.39% Short Float0.02% Perf Quarter10.24%
Sales143.33M P/S1.66 EPS this Y-5.50% Inst Trans- Short Ratio0.27 Perf Half Y4.78%
Book/sh3.13 P/B1.89 EPS next Y-17.30% ROA- Target Price9.00 Perf Year8.82%
Cash/sh- P/C- EPS next 5Y6.00% ROE- 52W Range4.63 - 6.70 Perf YTD18.40%
Dividend- P/FCF- EPS past 5Y117.91% ROI- 52W High-11.64% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low27.78% ATR0.15
Employees408 Current Ratio- Sales Q/Q120.80% Oper. Margin- RSI (14)73.96 Volatility3.66% 2.11%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume4.29 Prev Close5.96
ShortableYes LT Debt/Eq- EarningsNov 13 BMO Payout- Avg Volume24.68K Price5.92
Recom- SMA2011.98% SMA5013.52% SMA2005.88% Volume105,942 Change-0.67%
Feb-02-18Initiated Chardan Capital Markets Buy $7
Nov-13-19 08:15AM  Kamada (KMDA) Beats Q3 Earnings and Revenue Estimates Zacks
07:00AM  Kamada Reports Financial Results for Third Quarter and First Nine Months of 2019 GlobeNewswire
Nov-07-19 07:00AM  Kamada to Report Third Quarter 2019 Financial Results and Host Conference Call on November 13 GlobeNewswire
Nov-04-19 10:30AM  Kamada (KMDA) to Report Q3 Results: Wall Street Expects Earnings Growth Zacks
Oct-29-19 08:00AM  Kamada and Kedrion Biopharma Announce Publication of Results from the Registration Study of KEDRAB® (Rabies Immune Globulin ) in Human Vaccines & Immunotherapeutics Medical Journal GlobeNewswire
Sep-24-19 07:00AM  Kamada to Present Corporate Overview at the 2019 Cantor Global Healthcare Conference GlobeNewswire
Sep-03-19 07:00AM  Kamada Announces Extension of GLASSIA® Supply and Distribution Agreement with Takeda Through 2021 and Expected Transition of GLASSIA Manufacturing to Takeda GlobeNewswire
Aug-08-19 07:00AM  Kamada Reports Discussions with Takeda Regarding a Potential Extension of the Period for the Transition of GLASSIA Manufacturing to Takeda GlobeNewswire
Aug-07-19 03:23PM  Kamada Ltd. (KMDA) Q2 2019 Earnings Call Transcript Motley Fool
Aug-06-19 08:35AM  Kamada (KMDA) Q2 Earnings and Revenues Surpass Estimates Zacks
07:15AM  Kamada Reports Financial Results for Second Quarter and First Six Months of 2019 GlobeNewswire
Jul-31-19 07:00AM  Kamada to Report Second Quarter 2019 Financial Results and Host Conference Call on August 6 GlobeNewswire
Jul-30-19 10:38AM  Kamada (KMDA) Earnings Expected to Grow: What to Know Ahead of Q2 Release Zacks
Jul-19-19 10:57AM  Zacks.com featured highlights include: Kamada, Anhui Conch Cement, Air China and Air Transport Services Zacks
Jul-18-19 08:25AM  Look Beyond Earnings: 4 Stocks With Increasing Cash Flows Zacks
Jul-17-19 07:40AM  Zacks.com featured highlights include: Kamada, SunCoke Energy, Great Lakes Dredge & Dock, Herc and SYNNEX Zacks
Jul-16-19 09:53AM  New Strong Buy Stocks for July 16th Zacks
07:24AM  Tap These 6 Stocks That Flaunt Impressive Net Profit Margin Zacks
Jun-28-19 04:04PM  Cannabics Pharmaceuticals Gets New Directors Benzinga
May-17-19 02:30PM  Kamada Ltd. (KMDA) Q1 2019 Earnings Call Transcript Motley Fool
May-14-19 08:25AM  Kamada (KMDA) Tops Q1 Earnings and Revenue Estimates Zacks
07:18AM  Kamada: 1Q Earnings Snapshot Associated Press
07:00AM  Kamada Reports Financial Results for First Quarter of 2019 GlobeNewswire
May-13-19 06:47PM  Kamada (KMDA) to Report Q1 Earnings: What's in the Cards? Zacks
02:44PM  A Preview Of Kamada's Q1 Earnings Benzinga
May-07-19 05:45PM  Kamada (KMDA) Stock Moves -1.05%: What You Should Know Zacks
07:00AM  Kamada to Report First Quarter 2019 Financial Results and Host Conference Call on May 14 GlobeNewswire
May-01-19 05:45PM  Kamada (KMDA) Gains As Market Dips: What You Should Know Zacks
Apr-25-19 05:50PM  Kamada (KMDA) Gains As Market Dips: What You Should Know Zacks
Apr-24-19 09:30AM  Is Kamada (KMDA) Stock Outpacing Its Medical Peers This Year? Zacks
Apr-17-19 10:46AM  Kamada to Begin Phase III Study for Inhaled AAT Product in 2H Zacks
Apr-16-19 07:00AM  Kamada announces FDA acceptance of Inhaled AAT program path forward GlobeNewswire
Apr-12-19 09:46AM  5 Stocks With Increasing Cash Flows to Scoop Up Big Gains Zacks
Apr-11-19 10:43AM  Zacks.com featured expert Kevin Matras highlights: Herc, ANI Pharmaceuticals, Kamada, SP Plus and SkyWest Zacks
10:04AM  Acorda to Gain From Inbrija Sales and Neurological Pipeline Zacks
09:34AM  BioDelivery (BDSI) Buys US Rights to Pain Drug for $30M Zacks
Apr-10-19 05:50PM  Kamada (KMDA) Stock Sinks As Market Gains: What You Should Know Zacks
09:30AM  Tap These 6 Stocks That Flaunt Sizeable Net Profit Margin Zacks
Apr-09-19 11:24AM  PhaseBio Stock Up on Breakthrough Therapy Status for PB2452 Zacks
10:59AM  Emergent's (EBS) Strong Vaccine Portfolio to Fuel Growth Zacks
10:30AM  Inovio Earns 3rd Milestone Fee From AstraZeneca for MEDI0457 Zacks
Apr-08-19 09:30AM  Is Kamada (KMDA) Outperforming Other Medical Stocks This Year? Zacks
Apr-05-19 09:29AM  Puma Biotech Adds Two Cohorts to Nerlynx Label Expansion Study Zacks
Apr-04-19 05:50PM  Kamada (KMDA) Gains But Lags Market: What You Should Know Zacks
Apr-02-19 10:45AM  Puma Biotech Out-Licenses Nerlynx Rights in Europe, Stock Down Zacks
Apr-01-19 10:49AM  Seattle Genetics Closes Enrollment in Cervical Cancer Study Zacks
09:33AM  The Zacks Analyst Blog Highlights: ANI, Kamada, Genomic Health and NewLink Zacks
Mar-29-19 10:36AM  4 Small Biotech Stocks Likely to Witness More Upside in 2019 Zacks
Mar-28-19 11:18AM  Blueprint Medicines Expediates Filings for Key Candidates Zacks
10:04AM  Zacks.com featured expert Kevin Matras highlights: Kamada, Plantronics, SkyWest, SYNNEX and Walker & Dunlop Zacks
Mar-27-19 10:48AM  Agios (AGIO) Surges More Than 40% Year to Date: Here's Why Zacks
10:45AM  Agios Gains Breakthrough Therapy Status for Tibsovo Combo Zacks
09:03AM  Zacks.com featured expert Kevin Matras highlights: Kamada, Herc, Medifast, SkyWest and SP Plus Zacks
08:40AM  Bet on These 5 Stocks With Rising Cash Flows for Higher Gains Zacks
Mar-26-19 09:39AM  Best 6 Bets With Sound Net Profit Margin to Lift Portfolio Zacks
Mar-25-19 11:05AM  Lexicon Falls as FDA Denies Approval to Type I Diabetes Drug Zacks
Mar-22-19 09:30AM  Is Kamada (KMDA) Outperforming Other Medical Stocks This Year? Zacks
Mar-19-19 11:57AM  PhaseBio Stock Up on Positive Data From PB2452 Phase I Study Zacks
Mar-18-19 07:25AM  Lexicon Pharma Initiates Dosing in Biliary Tract Cancer Study Zacks
Mar-14-19 07:00AM  Kamada Awarded the Israeli Outstanding Exporter Award for 2017 GlobeNewswire
Mar-13-19 09:13AM  Zacks.com featured expert Kevin Matras highlights: Kamada, Plantronics, SkyWest, Middlefield and Walker & Dunlop Zacks
Mar-12-19 09:12AM  Scoop Up Big Gains With 5 Stocks Enjoying Rising Cash Flows Zacks
Mar-08-19 10:04AM  Achillion (ACHN) Reports Narrower-Than-Expected Loss in Q4 Zacks
07:16AM  Grab These 6 Stocks That Boast Substantial Net Profit Margin Zacks
Mar-07-19 09:06AM  Merrimack (MACK) Incurs Narrower-Than-Expected Loss in Q4 Zacks
Feb-27-19 09:00AM  Kamada Files Annual Report for the Year Ended December 31, 2018 GlobeNewswire
Feb-25-19 08:05AM  Focus on 6 Top-Ranked Stocks With Solid Net Profit Margin Zacks
Feb-20-19 09:10AM  Is Kamada (KMDA) a Great Value Stock Right Now? Zacks
Feb-12-19 06:22AM  Kamada: 4Q Earnings Snapshot Associated Press
06:00AM  Kamada Reports Financial Results for Fourth Quarter and Fiscal Year 2018 GlobeNewswire
Feb-06-19 07:00AM  Kamada Announces Additional Interim Results from Phase 2 Proof of Concept Clinical Trial of Intravenous Alpha-1 Antitrypsin Treatment for Prevention of Lung Transplant Rejection GlobeNewswire
Feb-05-19 07:00AM  Kamada to Announce Fourth Quarter and Fiscal Year Ended December 31, 2018 Financial Results and Host Conference Call on February 12 GlobeNewswire
Jan-30-19 07:00AM  Kamada Appoints Senior Biopharmaceutical Executive Michal Ayalon, Ph.D., as Vice President of Research and Development GlobeNewswire
Jan-02-19 07:00AM  Kamada Announces Preliminary Revenue for Fourth Quarter and Full-Year 2018 GlobeNewswire
Nov-12-18 08:55AM  Kamada (KMDA) Reports Q3 Loss, Misses Revenue Estimates Zacks
07:52AM  Kamada: 3Q Earnings Snapshot Associated Press
07:00AM  Kamada Reports Financial Results for Third Quarter and First Nine Months of 2018 GlobeNewswire
Nov-05-18 07:00AM  Kamada to Announce Third Quarter and Nine Months Ended September 30, 2018 Financial Results and Host Conference Call on November 12 GlobeNewswire
Oct-22-18 07:00AM  Kamada Announces Appointment of Life Sciences Industry Executive Eitan Kyiet as Vice President of Business Development GlobeNewswire
Sep-25-18 07:00AM  Kamada to Present Corporate Overview at the Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-05-18 07:00AM  Kamada Announces Extension of Collaboration with Massachusetts General Hospital for a Proof-of-Concept Study Evaluating the Potential Benefit of Liquid Alpha-1 Antitrypsin on Liver Preservation Prior to Transplantation GlobeNewswire
Aug-29-18 07:00AM  Kamada Provides Updated Full-Year 2018 Revenue Guidance GlobeNewswire
Aug-28-18 01:02PM  Cannabics Pharmaceuticals Inc. Appoints Dr. Estery Giloz-Ran to Its Advisory Board PR Newswire
Aug-16-18 07:00AM  Kamada Announces the End of the Labor Strike in the Companys Manufacturing Facility; All Employees Returned to Work GlobeNewswire
Aug-13-18 07:00AM  The Zacks Analyst Blog Highlights: American River, BG Staffing, Evolution Petroleum, Kamada and Farmers & Merchants Zacks
Aug-10-18 09:31AM  Dollar Strengthens on Turkey's Trouble: Top 5 Gainers Zacks
Aug-07-18 09:40AM  Kamada (KMDA) Surpasses Q2 Earnings and Revenue Estimates Zacks
08:37AM  Kamada: 2Q Earnings Snapshot Associated Press
07:00AM  Kamada Reports Financial Results for Second Quarter and First Six Months of 2018 GlobeNewswire
06:30AM  Kamada Ltd to Host Earnings Call ACCESSWIRE
Aug-01-18 07:00AM  Kamada to Announce Second Quarter and Six Months Ended June 30, 2018 Financial Results and Host Conference Call on August 7 GlobeNewswire
Jul-10-18 07:00AM  Kamada Receives Positive Scientific Advice from European Medicines Agency on a New Phase 3 Study Design for Inhaled AAT GlobeNewswire
Jun-28-18 09:30AM  Is Kamada (KMDA) Outperforming Other Medical Stocks This Year? Zacks
Jun-19-18 01:25PM  CVS will offer home delivery of prescriptions Yahoo Finance Video
12:25PM  4 Undervalued MedTech Stocks to Consider Amid Volatility InvestorPlace
Jun-15-18 09:13AM  5 Biotech Stocks Under $10 Worthy of Investors' Attention Zacks
Jun-04-18 07:00AM  Results of Kamadas Phase 2 Trial of Alpha-1 Antitrypsin in Newly Diagnosed Type-1 Diabetes Patients to be Presented at the Upcoming American Diabetes Associations 78th Scientific Sessions GlobeNewswire
May-25-18 01:46PM  Biotech and energy top list for best paying jobs Yahoo Finance Video
May-15-18 07:07AM  Kamada: 1Q Earnings Snapshot Associated Press
07:00AM  Kamada Reports Financial Results for First Quarter of 2018 GlobeNewswire
Kamada Ltd. develops, produces, and markets plasma-derived protein therapeutics for orphan indications. It operates through two segments, Proprietary Products and Distribution. The company offers respiratory products, including Glassia for use in augmentation and maintenance therapy in adults with emphysema due to congenital Alpha-1 Antitrypsin (AAT) deficiency. It also provides KamRAB for prophylaxis of rabies disease; KamRho (D) IM to treat prophylaxis of hemolytic disease of newborns; KamRho (D) IV for immune thermobocytopunic purpura; and snake bite antiserum to treat snake bites by the vipera palaestinae and echis coloratus, as well as human transferrin that is used as a cultural medium for diagnostic assays and cell cultures. In addition, Kamada Ltd. provides Heparin sodium injection to treat thrombo-embolic disorders; Albumin and Albumin 4% for maintenance of blood plasma; and coagulation factors comprising Factor VIII and Factor IX, as well as IXIARO vaccine. Its products in pipeline are G1-AAT (IV) for graft versus host disease and L1-AAT (1V) for lung transparent, which are in Phase II stage; and D1-AAT (IV) for type-1 diabetes, Inhaled AAT for AAT deficiency, and AAT (liquid) for lung preservation and recombinant AAT, which are in early stage development. Further, the company distributes respiratory products, including Bramitob to manage chronic pulmonary infection and FOSTER for the treatment of asthma; and immunoglobulins comprising IVIG 5% for the treatment of various immunodeficiency-related conditions; Varitect, a varicella zoster immunoglobulin; Zutectra and Hepatect CP for prevention of hepatitis B virus; and Megalotect, a CMV immunoglobulin. It markets its products through strategic partners in the United States, as well as through distributors internationally. Kamada Ltd. has strategic partnerships with Takeda Pharmaceutical Company Limited; PARI GmbH; and Kedrion S.p.A. Kamada Ltd. was founded in 1990 and is headquartered in Rehovot, Israel.